What’s Next? Five Things To Look Out For In January

Amgen’s Rituximab Biosimilar Set For Commercial Launch

 
• By Dean Rudge
  
Whats_Next_2020_2
Amgen is likely to discuss its rituximab biosimilar at Q4 earnings • Source: Informa

More from Generics

More from Products